Immune to Cancer: The CRI Blog
-
ASCO 2016 Update: Biomarker-Based Strategies
Molecular clues may help predict patient treatment and outcomes.
-
ASCO 2016 Update: Advances in Immunotherapy for Lung and Blood Cancers
Combination checkpoints, improved CAR T cells show promise.
-
ASCO 2016 Update: The Value of Combination Immunotherapy
Activating multiple immune pathways to improve patient outcomes.
-
ASCO 2016 Update: The Personal Side of Immunotherapy
To help more patients, treatments must get personal.
-
ASCO 2016: The Year of Immunotherapy
Chicago hosts top clinical cancer conference, immunotherapy shines.
-
What Cancer Patients Should Know: Latest Immunotherapy News from ASCO
Learn the latest news in cancer immunotherapy for melanoma, lung cancer, leukemia, liver cancer, and other cancer…
-
ASCO 2015: Report from Day 5
The last day of the ASCO meeting featured talks on immunotherapy for pancreatic cancer, one the deadliest…
-
ASCO 2015: Report from Day 4
More cancers prove treatable with checkpoint blockade therapy. Today: kidney, bladder, and ovarian cancer.
-
ASCO 2015: Report from Day 3
Immunotherapy for brain cancer and the results of a large clinical trial for patients with advanced melanoma.